CASP3 and diffuse large B-cell lymphoma: The caspase-3 activity of the hsa-miR-28-5p mimic + doxorubicin group was obviously different, exhibiting the highest apoptotic cell percentage and most potent anti-DLBCL therapeutic effect compared to the remaining three groups.